2021 ANNUAL MEETING
SEPT. 24-26 | HYATT REGENCY, DENVER
Welcome back to Denver!
VENUE
The AVAHO Program Planning Committee is pleased to announce the call for abstracts for our September 24-26, 2021 meeting. Currently, we are planning a combined in-person/virtual meeting to permit maximal participation by AVAHO members
AVAHO members are encouraged to submit abstracts on completed work – please follow the instructions and application form on the AVAHO website. Please note that data from for-profit or industry sources are not permitted. Abstracts should be free from commercial bias; promotional abstracts will not be accepted.
The first author is considered the primary author, is responsible for the content and integrity of the project, and will serve as the contact person by the AVAHO administrator and Planning Committee. Authors may submit more than one abstract; however, they may be first author on only one abstract. At least one author must be a member of AVAHO. Accepted abstracts will be published in a special edition of Federal Practitioner.
Please review the instructions below prior to developing the abstract. So that continuing education credits can be awarded for the poster session, all authors must complete relevant disclosure forms as delineated on the abstract submission form.
All abstracts will be scored by a blind-review process.
INSTRUCTIONS
Please review the following instructions carefully as you prepare your abstract. Changes have been made.
Abstracts are not to not exceed 350 words, excluding title. Titles should not exceed 300 characters. Authors’ names and institutions are not be included in the title or abstract but are to be submitted elsewhere in the submission.
Authors must identify which category is appropriate for your abstract. The following categories of abstracts are suitable for submission:
-
Research (e.g., clinical trials, laboratory studies, translational studies, descriptive studies, qualitative studies)
-
Quality Improvement Projects and Initiatives
-
Clinical Practice (e.g., best clinical practice exemplar, case study, disease management, palliative care (non-research), survivorship (non-research), symptom management (non-research)
-
Program Development/Project (e.g., workforce, infrastructure, workflow)
Projects must be completed – incomplete projects will not be accepted.
Illustrations, tables or bullet points are not permitted in the abstract.
Research, Evidence-Based Projects, and Quality Initiative Abstracts must address each of the following areas:
-
Purpose of the project
-
Relevant background – why is this a problem? What does the literature tell us?
-
Methods - what did you do to conduct the study/project?
-
Data analysis – what statistical tests were used?
-
Results – what did the data reveal?
-
Implications – how might these data be used to change practice or guide further research?
Clinical Practice Abstracts must address each of the following areas:
-
Thorough description of the clinical presentation or situation
-
Synthesis of relevant literature
-
Description of intervention(s) provided
-
Outcome of the intervention/situation
-
Implications for practice (clinical/administrative)
Program Development/Project must address each of the following areas:
-
Brief description of problem or needs assessment that led to developing program/project – why was the program/project needed?
-
Description of the program/project – provide the content of the program/project. Who was involved in developing the program/project?
-
Implementation – How was the program/project implemented? Was a pilot used?
-
Evaluation – What metrics were used to evaluate the impact of the program/project?
-
Outcome – What outcomes were achieved?
Note: Each abstract will be graded based on the extent each of the above criteria were met. Any omission will result in a lower score. All abstracts are scored by a blind-review process.
-
Abstracts must be free from commercial bias; promotional abstracts will not be accepted. Data from for-profit or industry sources are not permitted.
-
Accepted abstracts will be presented as e-posters. E-posters will be submitted as PowerPoint slides (5 slides maximum). Authors will be asked to record a five-minute presentation of their poster. Posters will be available for viewing throughout the meeting. Details regarding this recording will be forthcoming.
-
All authors of accepted abstracts will be required to complete a disclosure form as delineated on the abstract submission form.
Please contact Sue Lentz at 206-794-7022 or with any questions.
All abstracts must be submitted by 11:59 PM, PST July 1, 2021. This is a firm deadline. NO extensions!